LUXTURNA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 04 Jan 2024)
What this means for you
Registered since 26 Jun 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86910422
- Registration number
- 5503541
- Mark type
- Stylized text
- Filed
- 17 Feb 2016
- Published for opposition
- 12 Jul 2016
- Registered
- 26 Jun 2018
- Attorney of record
- Susan A. Smith
Goods and services
- Class 005 — Pharmaceuticals: Biologic preparations for the treatment of retinal diseases
Owner
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
- Spark Therapeutics, Inc., Philadelphia, PA, US
Prosecution history
- 04 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 04 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 04 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jul 2023 — TEAS SECTION 8 & 15 RECEIVED
- 26 Jun 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 26 Jun 2018 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 May 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 May 2018 — ASSIGNED TO EXAMINER
- 26 Apr 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Apr 2018 — USE AMENDMENT FILED
- 23 Apr 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Apr 2018 — TEAS STATEMENT OF USE RECEIVED
- 24 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Jan 2018 — SOU EXTENSION 3 GRANTED